humanova®: A Story of transformation, innovation, and purpose.
On April 16, the company was founded in Peru under the name Medifarma, launching its first line of branded medicines and marking the beginning of an era of innovation and commitment.
The Picasso Candamo economic group acquires Medifarma, introducing a new business vision focused on modernization, expansion, and technological development.
Medifarma becomes the first Peruvian laboratory to receive the Good Manufacturing Practices (GMP) Certification from the regulatory authority (DIGEMID), consolidating its position as a leader in quality and compliance within the pharmaceutical market.
Medifarma begins its industrial expansion and diversification by acquiring the Dr. Zaidman baby care product line.
Medifarma acquires Laboratorios Trifarma in Peru, specializing in the production of serums, and in the process adopts modern technological tools and highly sophisticated equipment to enhance efficiency, quality, and production capacity.
Medifarma takes its first international leap by acquiring Droguería Magma in Ecuador, entering both the retail and non-retail markets.
Medifarma acquires FARPASA (Farmacéutica del Pacífico) in Peru, adding key mass market and OTC products to its portfolio.
Medifarma acquires Droguería AKRON in Peru, strengthening its ophthalmology portfolio.
Medifarma enters the Brazilian market by acquiring Farmarin, a laboratory specialized in hemodialysis solutions, later expanding its portfolio with parenteral solutions.
Medifarma expands its presence in South America by entering the Uruguayan market through the acquisition of Laboratorio Fármaco Uruguayo. In the same year, the company enters the Paraguayan market with the acquisition of the distributor FUSA.
Medifarma takes a significant step in its history by entering the European market through the acquisition of Laboratorios Atral in Portugal, and simultaneously strengthens its presence in Peru with the acquisition of the distributor Pharbal.
Medifarma incorporates in Peru the Italian line of oral and dental care solutions from Droguería Gianfarma.
Medifarma acquires Laboratorios Hersil in Peru, positioning itself as the leader in the Peruvian pharmaceutical market. That same year, the company also acquired SINEX in Peru, strengthening its portfolio of hemodialysis solutions.
Medifarma enters Colombia by acquiring Corpaul, a laboratory specialized in hospital treatments such as serums and injectables.
Medifarma enters Chile with the acquisition of Laboratorio Sanderson, specialized in serums, ampoules, and hemodialysis concentrates, strengthening its hospital business and integrating its production capacity into the corporation’s regional operations.
With a renewed vision, we seek to play a high-impact role in people’s lives, building a global organizational culture that brings deeper meaning to our present business with a more human focus. We reaffirm our commitment to democratize and transform healthcare for the future we envision. The corporation launches its new brand identity under the name humanova®, reflecting our orientation toward placing the human being at the center of everything we do and unifying all group affiliates under one brand.
OUR PURPOSE
Transform the health of the world for the future we dream of.
We achieve greater results by connecting and bringing people together to create synergies where everyone moves forward.
We always act with respect, ethics, humanity, and transparency. We are aware of how our actions impact others.
We face challenges with determination and action, always striving to give our best, overcome barriers, and inspire others.
We move with a sense of urgency, acting quickly and proactively in everything we do, to achieve effective and efficient results that help us move forward faster.
